Related Experiment Videos
[Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Use of plasma-derived factor VIIa in a child with inhibitors of FVIII for the placement of an implantable intravenous access device.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Factor IX inhibition and epitope localization of factor IX inhibitor antibodies in haemophilia B patients with anaphylactoid reactions.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation.
Journal of thrombosis and haemostasis : JTH·2014
Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation.
Journal of thrombosis and haemostasis : JTH·2014
An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
[Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
[Complement-coagulation crosstalk in immunothrombosis].
[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Public transparency and physicochemical standardization in the regulation of PMMA dermal fillers: a comparative analysis of FDA, EU MDR, and ANVISA frameworks.
Regulatory toxicology and pharmacology : RTP·2026
A Corner-Analysis-Based Method for Dimensional Inspection and Defect Detection of Glass Chamfers.
Sensors (Basel, Switzerland)·2026
Development of a User Requirement Specification (URS) for a Biofluorescent Particle Counter (BFPC) for Surface and Personnel Monitoring in Aseptic Processing Areas: Poster Presented at PDA Week 2026.
PDA journal of pharmaceutical science and technology·2026
Bridging the Gap: Mitigating a Hidden Cleaning Risk in Large-Scale Freeze-Thaw Unit Commissioning: Poster Presented at PDA Week 2026.
PDA journal of pharmaceutical science and technology·2026